Castleview Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Castleview Partners's LLY Position: Q2 2026 in Review
Castleview Partners increased its Eli Lilly (LLY) stake by 31% in Q2 2026, buying an estimated $219K and bringing the position to 909 shares worth $1.09M. The position accounts for 0.48% of the portfolio, ranked #47.
Castleview Partners first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. 1,734 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Castleview Partners held 909 shares of Eli Lilly worth $1.09M as of Q2 2026.
- Castleview Partners bought 214 Eli Lilly shares in Q2 2026, an estimated $219K.
- Eli Lilly made up 0.48% of Castleview Partners's portfolio in Q2 2026, its #47 holding.
- Castleview Partners first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
- 1,734 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.